| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 16, 2026 | Buy(P) | 19 | $1.55 | $29 | 743K |
| Jul 16, 2026 | Buy(P) | 2 | $1.55 | $3 | 75K |
| Jul 15, 2026 | Buy(P) | 14K | $1.55 | $21K | 743K |
| Jul 15, 2026 | Buy(P) | 1K | $1.55 | $2K | 75K |
| Jul 14, 2026 | Buy(P) | 5K | $1.55 | $8K | 729K |
| Jul 14, 2026 | Buy(P) | 493 | $1.55 | $764 | 74K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-078891) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for InMed Pharmaceuticals Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.